✦ LIBER ✦

Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

✍ Scribed by Russell J. Schilder; John Blessing; David E. Cohn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin plus gemcitabine in previously

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; D. Scott McMeekin; Shas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II evaluation of oxaliplatin in pr

✍ Paula M Fracasso; John A Blessing; Judith Wolf; Thomas F Rocereto; Jonathan S Be 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Evaluation of Gemcitabine in Patients wi

✍ Russell J. Schilder; John A. Blessing; Mark Morgan; Charles E. Mangan; Janet S. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A Phase II Study of Topotecan in Patient

✍ Laila I. Muderspach; John A. Blessing; Charles Levenback; James L. Moore Jr.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Topotecan in Squamous Cell Carcinoma of

✍ Michael A. Bookman; John A. Blessing; Parviz Hanjani; Thomas J. Herzog; Willie A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II Trial of Menogaril in Patients

✍ Gregory P. Sutton; John A. Blessing; Rolland J. Barrett; Donald G. Gallup 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB